Family Medicine

Maternal Sepsis, Part 1: Introduction/Overview

Sepsis is the third leading cause of pregnancy-related death accounting for 23% of maternal deaths in the United States. To promote early recognition and rapid treatment, multiple professional organizations have provided screening and diagnostic criteria, and treatment recommendations. This series…

TOLAC Risk Issues

TOLAC is defined as a trial of labor after one or more cesarean deliveries intended to result in a vaginal birth instead of a scheduled repeat Cesarean Section. Successful vaginal birth after Cesarean (VBAC) rates in TOLAC patients are reported…

Labor Induction-Module 7: Oxytocin Safe Administration

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 6: Oxytocin Pharmacodynamics

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 5: Misoprostol

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 4: Mechanical Methods

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 3: Cervical Ripening

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 2: Indications, Contraindications, ARRIVE Trial

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Labor Induction-Module 1: Verdicts, Settlements, and a Case Study

In the US, “Mega” (> $10M) and “Nuclear” (> $100M) closed obstetric claims increased 84% in the last decade; obstetric care is a significant factor. Medications used for cervical ripening or labor induction can cause adverse outcomes when used inappropriately…

Emergency Medicine: Risk and Claims, Part 2

More than 60,500 active emergency physicians in the U.S. operate under time pressure within a high risk, high volume and often under resourced environment. They most often see a patient only once, usually in a situation in which the patient…